Nearly half of patients with advanced ovarian cancer treated with first-line poly-ADP-ribose polymerase (PARP) inhibitors experienced recurrence in this real-world study, emphasizing the need for ...

Parents vaccinated against COVID-19 were almost twice as likely to vaccinate their child against measles, mumps and rubella compared with unvaccinated parents, according to a study published in ...

Researchers suspect unmet treatment needs contribute to the shorter life expectancy for patients living with attention-deficit/hyperactivity disorder (ADHD).

Integrating lifestyle care into low back pain management resulted in greater improvements in disability, weight loss and physical quality of life vs. just guideline-recommended care, a randomized ...

Nivolumab plus chemotherapy improved long-term survival in Chinese patients with advanced gastric, GEJ, or esophageal cancer.

The phase 3 CheckMate 649 trial showed that nivolumab plus chemotherapy significantly improved long-term overall survival in Chinese patients with advanced gastric, gastroesophageal junction, and ...

CheckMate 649 trial showed sustained efficacy with frontline nivolumab plus chemotherapy vs chemotherapy alone in patients with gastric cancers.

The Food and Drug Administration (FDA) has approved Grafapex ™ (treosulfan) for injection with fludarabine as a preparative regimen for allogeneic hematopoietic stem cell transplantation (alloHSCT) in ...

A study of nearly 1,000 people with post-COVID-19 syndrome (PCS) revealed that two-thirds still experienced significant symptoms, including reduced exercise capacity and cognitive performance, two ...

Cancer patients with high muscle strength and cardiorespiratory fitness (CRF) had a significantly lower risk of death from any cause, including those with advanced cancers, a large retrospective ...

Friendswood ISD’s average daily attendance, or ADA, rose over the fall semester between 1%-2% in each campus compared to the 2023-24 school year, according to a Jan. 15 news release from the district.

Diagnosis of ADHD was tied to a 7-9-year reduction in life expectancy in adults compared to peers without ADHD, new data reveals.